Granules India rises as Virginia facility gets VAI classification

Image
Capital Market
Last Updated : Aug 26 2022 | 11:50 AM IST

Granules India rose 1.47% to Rs 311 after the USFDA classified Granules Pharmaceuticals, Inc's Virginia facility as Voluntary Action Indicated (VAI).

Granules Pharmaceuticals, Inc is a wholly-owned foreign subsidiary of the company located in Chantilly, Virginia, USA. The US drug regulator on 23 July 2022 had issued form 483 with 6 observations at this facility.

The company announced that the US Food and Drug Administration (USFDA) today classified the facility located at Chantilly, Virginia, USA as Voluntary Action Indicated (VAI). VAI means USFDA accepted the company's response to its observations.

Hyderabad-based Granules India is a vertically integrated fast growing Indian pharmaceutical company. It is present in the manufacturing of entire value chain - from active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs).

the drug maker reported a 6.1% rise in consolidated net profit to Rs 127.57 crore on a 20% increase in net sales to Rs 1,019.56 crore in Q1 FY23 over Q1 FY22.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 26 2022 | 11:13 AM IST

Next Story